Home LiteratureArticle Details
PMID: 8756 Published · ppublish English Case Reports Journal Article

Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin.

Pediatrics ·Vol. 58 ·No. 3 ·1976-09-00 ·Pages 378-81

Paredes A, Taber LH, Yow MD, Clark D, Nathan W

Abstract

For more than 30 years, penicillin has been the agent of choice for pneumococcal infections. During this time the majority of strains of Streptococcus pneumoniae have been highly susceptible to penicillin. However, during the last ten years there have been sporadic reports of pneumococci with increased resistance to penicillin. The case report of an 18-month-old white boy with meningitis due to a strain of S. pneumoniae with increased resistance to penicillin is presented. The MIC of the organism to penicillin was 0.2 mug/ml and the MBC 0.39 mug/ml. The patient had normal immunity and no demonstrable sequestered focus of infection but failed to respond to appropriate doses of intravenous penicillin. Treatment with chloramphenicol caused a dramatic bacteriologic and clinical response. This experience reemphasizes the existence of pneumococcal strains of intermediate penicillin sensitivity and the importance of in vitro susceptibility tests.

MeSH Terms
Humans Infant Male Meningitis, Pneumococcal/drug therapy,etiology,microbiology Microbial Sensitivity Tests Penicillin G/pharmacology,therapeutic use Penicillin Resistance Streptococcus pneumoniae/drug effects
Chemicals
Penicillin G
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Paredes A
Taber L H
Yow M D
Clark D
Nathan W
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
0031-4005
Published
1976-09-00
Pages
378-81
Language
English
Region
United States
NLM ID
0376422
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com